Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2007-10-02
2007-10-02
Layno, Carl (Department: 3766)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S024000
Reexamination Certificate
active
10460013
ABSTRACT:
Exemplary methods for decreasing workload, maintaining or increasing cardiac output and/or achieving a desirable autonomic balance by stimulating one or more parasympathetic nerves. Various exemplary methods include delivering one or more stimulation pulses postinspiration and/or based at least in part on detection of one or more cardiac event. Other methods and/or devices are also disclosed.
REFERENCES:
patent: 4712555 (1987-12-01), Thornander et al.
patent: 4788980 (1988-12-01), Mann et al.
patent: 4940052 (1990-07-01), Mann et al.
patent: 4944298 (1990-07-01), Sholder
patent: 5024222 (1991-06-01), Thacker
patent: 5199428 (1993-04-01), Obel et al.
patent: 5203326 (1993-04-01), Collins
patent: 5243980 (1993-09-01), Mehra
patent: 5330507 (1994-07-01), Schwartz
patent: 5334221 (1994-08-01), Bardy
patent: 5466254 (1995-11-01), Helland
patent: 5476483 (1995-12-01), Bornzin et al.
patent: 5507784 (1996-04-01), Hill et al.
patent: 5522854 (1996-06-01), Ideker et al.
patent: 5700282 (1997-12-01), Zabara
patent: 5836974 (1998-11-01), Christini et al.
patent: 6141590 (2000-10-01), Renirie et al.
patent: 6314323 (2001-11-01), Ekwall
patent: 6473644 (2002-10-01), Terry et al.
patent: 2002/0107553 (2002-08-01), Hill et al.
patent: 2003/0040774 (2003-02-01), Terry, Jr. et al.
patent: 0547734 (1992-07-01), None
patent: 0547734 (1992-07-01), None
patent: 1 106 206 (2000-11-01), None
patent: 1304135 (2003-04-01), None
patent: 1304135 (2003-12-01), None
Definition of “asynchronous” from dictionary.com.
Mizeres, “The Cardiac Plexus in Man1,” Amer. J. of Anatomy, 1963; 112:141-151.
Murakami et al., “Effects of Cardiac Sympathetic Nerve Stimulation on the Left Ventricular End-Systolic Pressure-Volume Relationship and Plasma Norepinephrine Dynamics in Dogs,” Jpn. Circ. J., 1997; 61:864-871.
Pauza et al., “Morphology, Distribution, and Variability of the Epicardiac Neural Ganglionated Subplexuses in the Human Heart”, Anatomical Record, 2000; 259:353-382.
Kawada et al., “Vagosympathetic Interactions in Ischemia-Induced Myocardial Norepinephrine and Acetylcholine Release,” Am. J. Physiol Heart Circ. Physiol., 2001; 280:H216-H221.
Shamsham et al., “Essentials of the Diagnosis of Heart Failure,” Amer. Fam. Phys., 2000; 61(5):1319-1328.
Cohn, “Preventing Congestive Heart Failure,” Amer. Fam. Phys., 1998; 57(8):1901-1904.
Frantz, “Beta Blockade in Patients with Congestive Heart Failure,” Postgrad. Med. 2000; 108(3):103-118.
Loh, “Overview: Old and New Controversies in the Treatment of Advanced Congestive Heart Failure,” J. of Cardiac Failure, 2001; 7(2:1):1-7.
Gomberg-Maitland et al., “Treatment of Congestive Heart Failure,” Arch. Intern. Med., 2001; 161:342-352.
Kirchheim et al, “Physiology and Pathophysiology of Baroreceptor Function and Neuro-Hormonal Abnormalities in Heart Failure,” Basic Res. Cardiol, 1998; 93(1):1-22.
Sokolovas et al, “Surgical Parasympathetic AV Node Denervation in a Canine Model: Anatomical and Electrophysiological Studies,” HeartWeb, 2002: vol. 2, No. 1, Article No. 96110010:1-8.
Krum, “Sympathetic Activation and the Role of Beta-Blockers in Chronic Heart Failure,” Aust NZ J Med., 1999; 29:418-427.
Shakar et al., “Low-Level Inotropic Stimulation with Type III Phosphodiesterase Inhibitors in Patients with Advanced Symptomatic Chronic Heart Failure Receiving β-Blocking Agents,” Current Cardio. Rpt., 2001; 3:224-231.
Chen et al., “Intracardiac Stimulation of Human Parasympathetic Nerve Fibers Induces Negative Dromotropic Effects: Implication with the Lesions of Radiofrequency Catheter Ablation,” J. Cardiovasc. Electrophysiol., Mar. 1998; vol. 9, No. 3: 245-252.
Lazzara et al., “Selective in Situ Parasympathetic Control of the Canine Sinoatrial and Strioventricular Nodes,” Circulation Research, Mar. 1973, vol. XXXII:393-401.
Schauerte et al., “Ventricular Rate Control During Atrial Fibrillation by Cardiac Parasympathetic Nerve Stimulation: a Transvenous Approach,” J. Am. College of Cardiology, 1999; vol. 34, No. 7:2043-2050.
Waninger et al., “Characterization of Atrioventricular Nodal Response to Electrical Left Vagal Stimulation,” Annals of Biomedical Eng, 1999; vol. 27:758-762.
Kulboka et al., “Changes of Heart Electrophysiological Parameters After Destruction of Epicardial Subplexuses that Innervate Sinoatrial Node,” Medicina, 2003; 39 Tomas, No. 6: 589-595.
Xiao-Jun Du et al., “Response to Cardiac Sympathetic Activation in Transgenic Mice Overexpressing β2-Adrenergic Receptor,” Amer. Phys. Soc., 1996; 0363-6135/96:H630-H636.
David Mendelowitz, “Advances in Parasympathetic Control of Heart Rate and Cardiac Function,” News Physiol. Sci., 1999; 14:155-161.
Layno Carl
Lee Yun Haeng
Pacesetter Inc.
LandOfFree
Vagal stimulation for improving cardiac function in heart... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vagal stimulation for improving cardiac function in heart..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vagal stimulation for improving cardiac function in heart... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3859422